miRNAs, such as miR-21, miR-155, and miR-196a, have been implicated in pancreatic cancer pathogenesis and can be combined with Gal-3 to improve diagnostic accuracy. This evidence concerns the gene LGALS3 and familial pancreatic carcinoma.